Assess evidence supporting current clinical guidelines for management of antithrombotic therapy in patients with CAD
|
|
|
|
|
|
Discuss the need for an optimal antithrombotic strategy for patients with AF with ACS and/or undergoing PCI
|
|
|
|
|
|
Evaluate the impact of emerging data on the management of this patient population in clinical practice
|
|
|
|
|
|
Determine the role of ASA in AF patients who develop ACS or undergo PCI
|
|
|
|
|
|